Protein inhibitor of Raf-1 kinase
Protein inhibitor of Raf-1 kinase
批准号:
6861829
负责人:
KAM C YEUNG
金额:
$21.35万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-01 至 2006-12-31
关键词:
affinity chromatographybiological signal transductionenzyme activityenzyme inhibitorsenzyme substrateion exchange chromatographymass spectrometrymitogen activated protein kinasenuclear factor kappa betaphosphorylationprotein bindingprotein kinaseprotein sequenceprotein structure functionsurface plasmon resonancewestern blottings
中文摘要
申请人描述:本提案的目的是研究新的
英文摘要
APPLICANT'S DESCRIPTION: The goal of this proposal is to study the newly
identified inhibitor of the Raf-l kinase designated RKJP. Raf-l is a
cytoplasmic serine/threonine kinase whose activity plays a pivotal role in the
control of the mitogen-activated protein kinase pathway (MAPK). Raf-1 kinase
activity is tightly regulated by an interplay of positive and negative
regulators. RKIP is a negative regulator of Raf-l and MAPK pathway signaling
that was recently identified in a collaborative effort between my lab and the
labs of Walter Kolch and David Rose. In this proposal I outline experiments to
investigate two aspects of RKJP function. In Aim One I will investigate in
detail the mechanism by which RKJP contributes to the regulation of the MAPK
pathway. Specifically, I will investigate the role of phosphorylation in the
regulation of the Raf-RKTP interaction. Several lines of evidence indicate that
RKJP binds to phosphorylated residues on proteins. I will thus investigate
whether the phosphorylation status of Raf- 1 plays a role in regulating the
RKIP-Raf- 1 interaction. The second set of experiments is based on the
observation that RKIP is a phosphoprotein in vivo and a substrate of several
kinases in vitro. Sites of in vitro phosphorylation will be mapped. In vivo
phosphorylation sites will be determined using a combination of mass
spectrometry and metabolic labeling followed by peptide mapping and sequencing.
Once in vivo sites are ascertained, phosphopeptide-specific antibodies will be
raised. The in vivo phosphorylation status of RKIP will be examined under a
variety of physiological conditions known to stimulate MAPK activity. In Aim
Two I will investigate the role of RKIP in the NF-KB signaling cascade. I have
obtained experimental evidence that modulation of RKIP expression levels
affects NF-kB activation, and I have shown that RKIP physically interacts with
two components of the NF-kB cascade, NIK and TAK 1. I will employ a combination
of genetic and biochemical methods to study the effects of RKIP on NF-kB
signaling. The primary goal of this line of investigation will be to define the
targets of RKIP in the NF-kB signaling pathway, and to initiate studies into
how they are regulated. In summary, I believe that the experiments in this
proposal will provide a new handle for understanding Raf- 1 signaling, and will
initiate studies to expose the full spectrum of RKIP functions.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.febslet.2009.12.051
发表时间:
2010-02-19
期刊:
FEBS letters
影响因子:
3.5
作者:
[Tang H, Park S, Sun SC, Trumbly R, Ren G, Tsung E, Yeung KC]
通讯作者:
Yeung KC
RKIP regulation as a potential for tumor suppression
-
批准号:7735834
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2009
-
负责人:KAM C YEUNG
-
依托单位:
RKIP regulation as a potential for tumor suppression
-
批准号:7895770
-
项目类别:
-
资助金额:$28.13万
-
财政年份:2009
-
负责人:KAM C YEUNG
-
依托单位:
Protein inhibitor of Raf-1 kinase
-
批准号:6328408
-
项目类别:
-
资助金额:$5.07万
-
财政年份:2001
-
负责人:KAM C YEUNG
-
依托单位:
Protein inhibitor of Raf-1 kinase
-
批准号:6520590
-
项目类别:
-
资助金额:$21.35万
-
财政年份:2001
-
负责人:KAM C YEUNG
-
依托单位:
Protein inhibitor of Raf-1 kinase
-
批准号:6712127
-
项目类别:
-
资助金额:$21.35万
-
财政年份:2001
-
负责人:KAM C YEUNG
-
依托单位:
Protein inhibitor of Raf-1 kinase
-
批准号:6484620
-
项目类别:
-
资助金额:$17.42万
-
财政年份:2001
-
负责人:KAM C YEUNG
-
依托单位:
Protein inhibitor of Raf-1 kinase
-
批准号:6636708
-
项目类别:
-
资助金额:$21.35万
-
财政年份:2001
-
负责人:KAM C YEUNG
-
依托单位:
海外基金